BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum
- 2026 marks BIO-Europe’s evolution from partnering-led conference into the continent’s largest biopharma strategy forum
- Expands its program to convene the full C-suite of strategy leaders, building on its commitment to open dialogue and constructive partnerships
- Seven integrated tracks and high-impact plenary sessions to address the forces reshaping the global biopharma industry
London, UK – 18 June 2026 – BIO-Europe, the must-attend global biopharma partnering event, today announces a bold new vision for its 32nd annual conference to be held in Cologne, Germany, from 9-11 November 2026. The vision moves BIO-Europe beyond Europe’s largest partnering event to become the neutral, credible forum where the full biopharma C-suite shapes not just partnerships, but the strategic direction of the industry worldwide.
